Cancer Therapy News and Research

RSS

New drug works better than current treatments for advanced kidney cancer

A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.

29 Sep 2015

Fewer, higher doses of radiotherapy effective at treating prostate cancer

Giving fewer but higher doses of radiotherapy, is as effective at treating prostate cancer as giving lower doses for a longer period, according to new research* presented at the 2015 European Cancer Congress today (Monday).

28 Sep 2015

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

Kolltan Pharmaceuticals, Inc. today announced the presentation of data from a preclinical study evaluating KTN0158 in dogs with spontaneous mast cell tumors. KTN0158 is a proprietary, humanized anti-KIT IgG1 monoclonal antibody drug candidate being developed as a potential therapy for cancer and mast cell-related diseases.

28 Sep 2015

Hormonal therapy may protect women's ovaries, increase chances of pregnancy after breast cancer treatment

Young women undergoing chemotherapy for breast cancer may be more likely to remain fertile if they also receive hormonal treatment, according to new research presented to the 2015 European Cancer Congress on Monday and published simultaneously in Annals of Oncology.

28 Sep 2015

JRC, CERN to explore potential of accelerator-driven method for producing targeted alpha therapy for cancer

A novel, accelerator-driven method could produce nuclides for targeted alpha therapy of cancer in practically unlimited amounts, overcoming current obstacles for its wider use due to a limited production of alpha-emitters. The JRC and the Conseil Européen pour la Recherche Nucléaire have embarked to explore the potential of the jointly proposed method.

24 Sep 2015

TUM, Stanford University scientists create new cancer therapy concept

Pancreatic cancer is one of the most aggressive forms of cancer and one of the most difficult to treat. Its high resistance to treatment is a major problem, particularly in the advanced stages.

24 Sep 2015

Study explores effectiveness of frontline treatments for couples with unexplained infertility

A breast cancer drug with promise for improving the chance that couples with unexplained infertility can have a baby without increasing their risk of multiple births apparently does not deliver, according to a comparative study.

24 Sep 2015

Innovative new device improves breast cancer treatment

A surgeon with the Breast Health Center at Women & Infants Hospital of Rhode Island, a Care New England hospital, is among the first in New England to adopt an innovative new device that improves the treatment of breast cancer by more precisely targeting radiation treatment and providing for better follow-up exams.

23 Sep 2015

BWH, DFCI researchers receive $10 million to test effectiveness of aspirin in women with breast cancer

Researchers from Brigham and Women's Hospital and Dana-Farber Cancer Institute have received a $10 million Breakthrough Award from the Department of Defense's Office of the Congressionally Directed Medical Research Program to test whether aspirin helps women with breast cancer avoid recurrence and live longer.

22 Sep 2015

CTCA at Western begins clinical trial that combines immunotherapy with chemotherapy to target sarcomas

Cancer Treatment Centers of America at Western Regional Medical Center in Goodyear, Arizona, has begun Phase II of another arm of its multi-arm clinical trial that combines immunotherapy with chemotherapy.

21 Sep 2015

Artificial intelligence may improve outcomes in breast cancer patients

Western University researchers are working on a way to use artificial intelligence to predict a patient's response to two common chemotherapy medications used to treat breast cancer - paclitaxel and gemcitabine.

19 Sep 2015

Cancer-causing gene disrupts internal rhythm, metabolic pathways in cancer cells

Myc is a cancer-causing gene responsible for disrupting the normal 24-hour internal rhythm and metabolic pathways in cancer cells, found a team led by researchers from the Perelman School of Medicine at the University of Pennsylvania. Postdoctoral fellow Brian Altman, PhD, and doctoral student Annie Hsieh, MD, both from the lab of senior author Chi Van Dang, MD, PhD, director Abramson Cancer Center, study body clock proteins associated with cancer cells.

18 Sep 2015

Gynaecological cancer still remains a taboo subject

They're thrown into menopause in their twenties, lose the possibility to have biological children, and struggle with their sex life.

18 Sep 2015

Specific biomarker predicts which HER2-negative breast cancer patients respond to targeted therapy

A multicenter team led by Case Western Reserve has demonstrated that brief exposure to a targeted therapy can tell doctors which HER2-negative patients will respond — and which should switch to another kind of treatment.

18 Sep 2015

Hitachi receives FDA 510(k) clearance to deliver new PROBEAT-V system to Rochester-based Mayo Clinic

Hitachi, Ltd. has announced it has received FDA 510(k) clearance for commercial supply of the new PROBEAT-V system, which it designed and developed for Mayo Clinic in Rochester, MN. Treatments began in late June and the first patient treatment was completed in August 2015.

16 Sep 2015

Massage therapy improves health related quality of life for cancer patients

Recent studies show massage therapy can reduce pain, stress, nausea, depression, distress, anxiety and fatigue, while improving health related quality of life for cancer patients.

15 Sep 2015

Findings suggest link between cancer drug resistance and reactive oxygen species found in mitochondria

Increased levels of certain chemically reactive, oxygen-containing molecules in the body can cause patients to become resistant to cancer drugs such as chemotherapy, according to researchers at Georgia State University.

15 Sep 2015

Study reveals how leukemia cells evade deadly effects of BRD4 inhibitors

BRD4 inhibitors are among the most promising new agents in cancer therapy that are currently evaluated in clinical trials.

15 Sep 2015

Cancer Research UK introduces three new funding schemes to support careers of cancer doctors

Cancer Research UK is launching three new funding schemes to support the careers of cancer doctors researching new ways to prevent, diagnose and treat the disease.

15 Sep 2015

NanoString announces key initiatives to expand market for nCounter Analysis System, related product portfolio

At a meeting with analysts and investors today, members of the senior management team of NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, plan to unveil the company’s strategic roadmap to drive continued growth and expand the market for its nCounter Analysis System and the related product portfolio.

From NanoString Technologies 14 Sep 2015

Cancer Therapy News and Research

New drug works better than current treatments for advanced kidney cancer

Fewer, higher doses of radiotherapy effective at treating prostate cancer

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

Hormonal therapy may protect women's ovaries, increase chances of pregnancy after breast cancer treatment

JRC, CERN to explore potential of accelerator-driven method for producing targeted alpha therapy for cancer

TUM, Stanford University scientists create new cancer therapy concept

Study explores effectiveness of frontline treatments for couples with unexplained infertility

Innovative new device improves breast cancer treatment

BWH, DFCI researchers receive $10 million to test effectiveness of aspirin in women with breast cancer

CTCA at Western begins clinical trial that combines immunotherapy with chemotherapy to target sarcomas

Artificial intelligence may improve outcomes in breast cancer patients

Cancer-causing gene disrupts internal rhythm, metabolic pathways in cancer cells

Gynaecological cancer still remains a taboo subject

Specific biomarker predicts which HER2-negative breast cancer patients respond to targeted therapy

Hitachi receives FDA 510(k) clearance to deliver new PROBEAT-V system to Rochester-based Mayo Clinic

Massage therapy improves health related quality of life for cancer patients

Findings suggest link between cancer drug resistance and reactive oxygen species found in mitochondria

Study reveals how leukemia cells evade deadly effects of BRD4 inhibitors

Cancer Research UK introduces three new funding schemes to support careers of cancer doctors

NanoString announces key initiatives to expand market for nCounter Analysis System, related product portfolio

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News